**INTRODUCTION:** The use of Negative-Pressure Wound Therapy (NPWT) on post-sarcoma resection wounds with uncertain margins is controversial due to the fear that it could promote cancer cell growth. There is no clinical or basic science data to address this theoretical concern. This study investigates the safety of NPWT following sarcoma resection by comparing local recurrence rates and wound-healing outcomes for NPWT and non-NPWT patients with open wounds following sarcoma resection.

**MATERIALS AND METHODS:** A retrospective analysis was performed on all patients who underwent extremity or superficial sarcoma resection at a single center over a 10-year period (2005--2015). Patients with open wounds following sarcoma resection and at least 6 months of follow up were included in this study cohort. Data on wound healing, tumor pathology, and recurrence were collected. Fisher's Chi-square and Student's t-test were used to determine statistical significance.

**RESULTS:** Of the 129 sarcoma patients who underwent resection during the study period, 18 had open wounds after resection, and eight patients received NPWT. Median follow up was 932 days. Tumor grade (\>0.05) and wound size following resection (p = 0.276) were similar between the NPWT and non-NPWT groups. The recurrence rate of patients with NPWT was 0%, while the recurrence rate of patients without NPWT was 20% (p = 0.477). Time to wound healing (p = 0.699) and wound complications (infection, wound dehiscence, bleeding, or hematoma) were similar between the two groups (p\>0.05). There was no difference in time to adjuvant treatment between the two groups (n=5 for NPWT, and n=3 non-NPWT, p=0.515).

**CONCLUSIONS:** Based on our results, NPWT use after sarcoma resection is not associated with increased local recurrence. Time to wound healing was not significantly different between NPWT and non-NPWT patients. A limitation of this study was its small sample size, and further larger scale studies are indicated.
